← back to search

Linlin Cheng

Chinese Academy of Medical Sciences & Peking Union Medical College · CN
Area of research
Ophthalmology · Infectious Diseases
Research interest
Research interests include Ocular Diseases and Behçet’s Syndrome, SARS-CoV-2 and COVID-19 Research, Vasculitis and related conditions, and Inflammatory Myopathies and Dermatomyositis.
h-index
14
citations
1,093
works
59
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Autoantibody reactome analysis reveals diagnostic biomarkers and molecular classification for relapsing polychondritis
Annals of the Rheumatic Diseases 2025cited by 2position: middledoi
Ferritin in the coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
Journal of Clinical Laboratory Analysis 2020cited by 393position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Haolong Li · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2020–2025)Yongzhe Li · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2020–2025)— · 1 papers (2025–2025)Chenxi Liu · Sichuan University1 papers (2020–2020)Lei Zhang · Nanchang University1 papers (2025–2025)Zhan Li · South China Agricultural University1 papers (2025–2025)Xiaobo Yu · Neurological Surgery1 papers (2025–2025)Xinxin Feng · University of Illinois Urbana-Champaign1 papers (2025–2025)— · 1 papers (2025–2025)Min Feng · Hunan University of Traditional Chinese Medicine1 papers (2025–2025)Siyu Wang · Allen Institute for Brain Science1 papers (2025–2025)Zijuan Zhang · Jiangsu University1 papers (2025–2025)Jing Luo · Jinan University1 papers (2025–2025)Songxin Yan · Fujian Medical University1 papers (2020–2020)— · 1 papers (2025–2025)— · 1 papers (2025–2025)Haizhen Chen · Jilin University1 papers (2020–2020)Yong Hou · Ministry of Education of the People's Republic of China1 papers (2025–2025)Mengzhu Zhao · Ministry of Education of the People's Republic of China1 papers (2025–2025)Liubing Li · Sun Yat-sen University1 papers (2020–2020)